Used as a key intermediate in the synthesis of fluorinated pharmaceuticals, particularly in the development of antidiabetic drugs such as DPP-4 inhibitors. Its fluorinated structure enhances metabolic stability and bioavailability in active compounds. Also employed in the preparation of enzyme inhibitors and bioactive molecules where fluorine substitution improves binding selectivity and pharmacokinetic properties. Commonly utilized in medicinal chemistry research for designing peptidomimetics and neuroactive agents.